Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **bacterial small ribosomal subunit 30S** is a fundamental component of the prokaryotic protein synthesis machinery. It consists primarily of a single large RNA molecule—16S rRNA—and approximately 20–21 associated proteins. The main functions include binding messenger RNA and transfer RNAs during translation, ensuring accurate base-pairing between codon and anticodon ("decoding"), and initiating protein synthesis by recognizing specific sequences on mRNAs such as the Shine-Dalgarno sequence. The structure provides critical sites for interaction with several classes of antibiotics that inhibit bacterial growth by disrupting these processes. Many clinically important antibiotics—including aminoglycosides like streptomycin and gentamicin—bind directly to this subunit, interfering with its role in decoding genetic information or translocating tRNAs during elongation. Because it is essential for bacterial viability but structurally distinct from eukaryotic counterparts, it serves as an important therapeutic target for antibacterial drugs.
Drugs targeting the 30S subunit typically act by one or more of the following mechanisms: Inhibiting decoding accuracy, causing misreading of mRNA codons (e.g., aminoglycosides like streptomycin, gentamicin, paromomycin); Blocking tRNA binding to the A-site or interfering with translocation along mRNA (e.g., spectinomycin); Preventing proper assembly or function of the initiation complex.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial small ribosomal subunit 30S (30S subunit).